sr No. | Lung | Histological grading | Lymph node metastasis | Vasular invasion | Clinical Staging | IHC | Ki67 | Renal | IHC | Histological grading | Vasular invasion | Ki67 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ACA | P | Y | UN | IVA | CK7+,TTF-1+,NapsinA+, P63-, P40-,Syn-, CgA-,CD56- | 80% | ACA | CK(AE1/AE3)+,CK7+, TTF-1+,NapsinA+, PAX-8-,GATA3- | P | Y | 60% |
2 | ACA | M | Y | Y | IIB/ pT1cN1M0 | CK7+,TTF-1+,NapsinA+, P63-, P40-,Syn-, CgA-,CD56- | 10% | ACA | CK(AE1/AE3)+,TTF-1+, NapsinA+,PAX-8- | P | N | 3% |
3 | Small-cell CA | P | Y | UN | IIIB | TTF-1+,Syn+,CgA+, CD56+,CK7-,NapsinA-, P63-, P40- | 90% | Small-cell CA | Syn+, CgA+, TTF-1+,GATA3- | P | UN | 60% |
4 | SCC | P | UN | UN | IIB | P63+,P40+,TTF-1-,CK7-, NapsinA-,Syn-,CgA-,CD56- | 40% | SCC | CK(AE1/AE3)+,P63+, P40+,PAX-8-,GATA3- | P | UN | 30% |
5 | ACA | M | UN | UN | IIIA | CK7+,TTF-1+,NapsinA+, P63-, P40-,Syn-, CgA-,CD56- | 70% | ACA | CK(AE1/AE3) +, TTF-1 +, NapsinA+, GATA3- | M | UN | 40% |
6 | ACA | M | N | N | IA3 / pT1cN0M0 | CK7+,TTF-1+,NapsinA+, P63-, P40-,Syn -, CgA-,CD56- | 60% | ACA | CK7+,TTF-1+, NapsinA+,PAX-8-,GATA3- | M | N | 20% |